Latest updates of this page
2023
- 7th June: Added titles of talks and for some of them slides of LIDS conference.
- 21th April: Added slides and recordings of BBS seminar Quantification of risk: ask the right questions or time to apply the estimand framework to safety! to past events page.
- 19th April: The paper on Logic-Respecting Efficacy Estimands has been accepted by Statistics in Biopharmaceutical Research.
- 15th March: The paper on quantification of follow-up has been accepted by Pharmaceutical Statistics.
- 30th January:
- Updated status of task forces.
- The group will give an invited talk around the topic of estimands at the Nordic lymphoma meeting in November.
2022
- 21th December: The duration of response has submitted a paper including code. See publications.
- 16th December: Latest newsletter to the group.
- 15th December: The WG has been granted an entire session at the 2023 PSI Conference in London, see here for the agenda.
- 3rd December: Added slidedecks and link to recording of ASA New Jersey Chapter Webinar Series: Getting the question right: Applying the Estimand and Target Trial Frameworks with External Controls to events.
- 29th November: Updated roster of Time to event endpoints with prognostic or predictive biomarker subgroups task force.
- 25th November:
- Moved this page to quarto implying a slightly different look.
- Added 2022 achievements.
- 16th November: Jonathan Siegel will give a presentation on estimands for time-to-event endpoints at the Duke Industry Statistics Symposium 2023 in March 2023, see events for details.
- 15th November: Together with ASA NJ chapter the WG is co-organizing a webinar, see events for details.
- 24th October: Added slides of the conditional and marginal taskforce presented at a DIA China webinar.
- 11th October: Latest newsletter to the group.
- 24th September: Added slidedecks from recent conferences.
- 1st July: Added slidedeck and written updates of recent full group TC.
- 29th June: After submission of its paper (see publications) the follow-up quantification task force is now inactive.
- 17th June: Added talks from our session at the PSI conference in Gothenburg.
- 13th June: Paper from follow-up quantification task force posted on arXiv. See publications.
- 23th May: Latest newsletter to the group.
- 17th May: updated events page with past and upcoming appearances of the WG.
- 26th March: added slidedeck and recording of Graham Dunn Seminar to events page.
- 8th March: arxiv links added for the two submitted papers of the censoring subteam.
- 4th March: We have now officially started work in the safety taskforce. Many thanks to Jonathan Siegel for starting and leading this!
- 3rd February: Congratulations to the authors of Sun et al. and Bornkamp et al. - these papers were the 3rd and 4th most downloaded papers that appeared in 2021 in Pharmaceutical Statistics.
- 26nd January: The censoring subteam has submitted two papers, see publications.
2021
- 22nd December: Added slidedeck on backfitting MMRM of PRO task force, see their entry here.
- 6th December: Latest newsletter to the group.
- 26th November: Added new page Further resources with links to other estimand working groups (we are aware of) and a section with introductory estimand material.
- 13th October: Added remit of Task Force 2.
- 30th September: Added slidedeck from recent, under events.
- 22th September: Added new paper by Hampson et al. to publications.
- 17th September: Latest newsletter to the group.
- 2nd September: Added announcement of DIA webinar: Estimands How and Why - A Real Life Case Study in Oncology on events page.
- 25th July: Added a section on collaborations to the organization tab.
- 10th July: The paper on treatment switching has been accepted by Pharmaceutical statistics.
- 22th June: New design of this webpage online.
- 15th June: Added slidedeck that the clinical engagement subteam presented at the Society for Clinical Trials conference 2021.
- 7th June: Added slidedeck and recording from PSI EIWG Webinar: Estimands in Oncology - How and Why, updated team roster.
- 3rd May: Added members of EDEN task force.
- 28th April: The WG offers a new webinar PSI EIWG Webinar: Estimands in Oncology - How and Why, targeted at Clinicians, Investigators, Regulatory Experts, Medical Writers, Ethics Committees, Statisticians.
- 13th April: Kickoff of EDEN (Early Development Estimand Nexus) task force.
- 22th March: Natalia Kan-Dobrosky will talk at the Duke Industry Statistics Symposium on “Estimands in clinical trials with treatment switching”.
- 5th March: Two sessions with involvement of the WG at this year’s ASA Biopharmaceutical Section Regulatory-Industry Statistics Workshop 2021, see below for details.
- 28th February: Added rosters and objectives of task forces.
- 11th February: Added slides presented by Evgeny and Kaspar at ASA - FDA - LUNGevity symposium “Statistical considerations in Oncology clinical trials in the COVID-19 era”.
- 5th February: Papers on principal stratification and hematology case studies both accepted for publication by Pharmaceutical Statistics. See publication section.
- 30th January: Kick-off of new task forces.